Lower-dose and maintenance plans at the programs we compare (Nov 12, 2026)
| Plan | Program | Form | From |
|---|---|---|---|
| Microdosed tirzepatide | Enhanced | Weekly shot | $79/mo (12-month plan) |
| Microdose semaglutide or tirzepatide | Lttl | Weekly shot | $109/mo (12-month plan) |
Microdose and lower-dose plans as named by each program, read on their own sites; "from" = the lowest price shown. A clinician decides whether a lower dose suits you.
The timeline after the last dose
Semaglutide's half-life is about a week and tirzepatide's about five days, so the drug fades over roughly four to five weeks. Digestive side effects ease first. Appetite and "food noise" return gradually over the same weeks; by two to three months most people eat as they did before treatment unless habits changed.
What the trials show about regain
In the STEP 1 extension (327 people), those who stopped semaglutide after 68 weeks had lost 17.3% on average and regained about two-thirds of it by week 120, ending about 5.6% below their starting weight. The lifestyle program stopped at the same time, so this is close to a worst case. Blood pressure and blood-sugar improvements also moved back toward baseline.
Tirzepatide trials found the same pattern: people switched to placebo regained much of their loss, while those who stayed on kept it.
Your options instead of a full stop
- Stay on a lower maintenance dose your clinician sets.
- Move to a cheaper plan: compounded semaglutide from $59 or tirzepatide from $96 a month, vs. $273 for Wegovy.
- Use a microdose plan, from $79 a month (table above).
- If you stop, keep protein high, keep strength training, weigh in weekly and agree with your clinician on a weight at which you'll restart.






